Trial 2 in the elevated plus-maze: a different form of fear?

Psychopharmacology

Volumn 111, Issue 4, 1993, Pages 491-494

  File, Sandra E ^a   Zangrossi Jr , Helio ^a   Viana, Milena ^b   Graeff, Frederico G ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anxiety; Benzodiazepines; Fear; Tolerance

Indexed keywords

DIAZEPAM;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; FACTORIAL ANALYSIS; FEAR; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; TECHNIQUE; TRANQUILIZING ACTIVITY;

ANIMAL; ANXIETY; DIAZEPAM; EXPLORATORY BEHAVIOR; FEAR; HANDLING (PSYCHOLOGY); MALE; MODELS, PSYCHOLOGICAL; PHOBIC DISORDERS; RATS; SUPPORT, NON-U.S. GOV'T;

EID: 0027234374     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF02253541     Document Type: Article

References (9)

1. Early life protein malnutrition changes exploration of the elevated plus-maze and reactivity to anxiolytics
2. Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors
3. One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze
4. The biological basis of anxiety
5. Characterisation of the phenomenon of “one-trial tolerance” to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze
6. Modification of chlordiazepoxide's behavioural and neurochemical effects by handling and plus-maze experience
7. The use of a plus-maze to measure anxiety in the mouse
8. Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience